Medical Weight Loss · Eligibility Check

Am I a candidate for GLP-1 weight-loss medication?

A few quick questions to see whether you might meet the medical criteria for semaglutide (Wegovy) or tirzepatide (Zepbound), and what to confirm with a provider.

Educational only — not medical advice, a diagnosis, or a prescription. These are prescription medications; only a licensed medical provider can confirm eligibility, screen for contraindications, and prescribe. For adults; anyone under 18 must be assessed by a provider.

How this assessment works & sources

This self-check reflects FDA-approved eligibility and the boxed-warning contraindications for GLP-1 weight-loss medications (semaglutide / Wegovy and tirzepatide / Zepbound). It never diagnoses or prescribes — only a licensed medical provider can.

Eligibility (BMI ≥30, or ≥27 with a weight-related condition), boxed warning & contraindications — FDA label: Wegovy · FDA label: Zepbound
Average trial weight loss (semaglutide ~15%, tirzepatide ~20%) — NEJM STEP-1 · SURMOUNT-1
Prescription-only, medical supervision — Mayo Clinic